Eris Lifesciences posts consolidated Q4FY23 PAT at Rs. 65.41 Cr
News

Eris Lifesciences posts consolidated Q4FY23 PAT at Rs. 65.41 Cr

Eris Lifesciences has reported total income of Rs. 403.80 crores during the period ended March 31, 2023

  • By IPP Bureau | May 22, 2023

Eris Lifesciences Limited has posted net profit of Rs. 65.41 crores for the period ended March 31, 2023 as against net profit of Rs. 101.85 crores for the period ended December 31, 2022. The company posted net profit of Rs.80.296 crores for the period ended March 31, 2022.

Eris Lifesciences has reported total income of Rs. 403.80 crores during the period ended March 31, 2023 as compared to Rs. 425.49 crores during the period ended December 31, 2022. The company reported total income of Rs.314.01 crores during the period ended March 31, 2022.

For the Financial Year ended March 31, 2023, Eris Lifesciences has reported total income of Rs.1696.30 crores as compared to Rs.1373.13 crores during the Financial Year ended March 31, 2022.

The company has posted net profit of Rs.382.15 crores for the Financial Year ended March 31, 2023 as against net profit of Rs.406.11 crores for the Financial Year ended March 31, 2022.

 

Upcoming E-conference

Other Related stories

Startup

Digitization